Feature | September 01, 2010

Heart Rhythm Society Study Shows Increasing EP Demand


September 1, 2010 – A new study on overall workforce trends in the field of cardiac electrophysiology (EP) reveals an increasing demand for EP professionals as a result of shifting demographic trends, evolving health reform policies and improved procedural outcomes. The comprehensive workforce study published in the September issue of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, found substantial growth in the overall volume and complexity of cardiac procedures performed in the past decade.

The study, commissioned in 2009 by the Heart Rhythm Society, provides data from nearly 700 respondents, including EPs, allied professionals and basic scientists currently working within the field of cardiac electrophysiology. The median age of physician respondents was 50 years with the majority falling between 46 and 55 years of age. While the average work week for physician respondents is 60 hours, nearly 30 percent work between 61 and 75 hours a week. For every respondent age-range queried the workload is expected to increase over the next five years for EPs, allied professionals and basic scientists alike.

“The field of cardiac electrophysiology continues to evolve as physicians are faced with new challenges in a changing healthcare environment,” said lead author Thomas F. Deering, M.D., FHRS, CCDS, Piedmont Heart Institute in Atlanta, Ga. “As seen from this study, electrophysiologists must embrace the advancements in technology and adapt to the changes in healthcare reform in order to continue to deliver high-quality care to a growing patient population.”

Work Capacity
Study results found that most physicians anticipate an increased workload in response to several key factors, including an aging patient population, broader access to care, possible expansion in indications for specific therapies (such as device implantation and ablation procedures), increasingly complex procedures and a potentially decreasing workforce as the current workforce gets older, cuts their hours and/or retires.

Approximately one quarter of physicians are highly specialized in the type of procedural work they perform with 25 percent of the physician respondents spending more than 85 percent of their procedural work time on either device or ablation procedures. In general, practice time is predominantly spent on device implantations, device follow-up and ablations. Some of these activities, such as complex device or ablation procedures, are being tasked to younger physicians indicating a growing need for more well-trained allied professionals to assume a greater role in device management. Furthermore, nearly two-thirds of all respondents are currently at or exceeding their perceived workload capacity for device therapies and catheter ablation.


Device Implantation, Follow-Up
More than 55 percent of the physician respondents indicated that the total number of implantation procedures they performed each year compared to five years ago had increased. Additionally, the follow-up of implanted devices was the largest percentage of activity reported, on average more than 200 performed annually per respondent. Currently, allied professionals play a significant role in managing device patient follow-up, and this need will steadily increase as the number of device patients continues to rise. Overall, device implantation accounts for nearly one-fourth of the survey respondent’s workweek. And, pacemaker and implantable cardioverter-defibrillator (ICD) implantations are performed equally by physician respondents of all ages; whereas, cardiac resynchronization therapy (CRT) device implantation is more common among young or mid-career physicians.


Ablation Procedures
According to the study, the median proportion of time each respondent spends on ablation procedures during the workweek is 15.8 percent. Supraventricular tachycardia (SVT) procedures were the most common – with 76.9 percent of survey respondents having performed an SVT in the last 12 months. SVT ablation became less common as the age range of respondents increased. Like SVT ablations, older respondents were less likely to perform VT ablations. Atrial fibrillation (AF) ablation was performed less often. In general, the survey found AF and VT ablation are almost exclusively performed by early and mid-career physicians.

“Building a steady pipeline of emerging EPs, meeting the educational and training needs of allied professionals and fostering the growth of basic science is critically important as the demand for cardiac electrophysiology continues to grow,” Deering said.


For more information: www.heartrhythmjournal.com

Related Content

Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.

Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.

News | EP Lab | June 02, 2021
June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions, annou
Left, the AcQCross Transseptal Crossing Device offers versatility to be utilized with top sheaths currently used in left atrium EP and structural heart procedures. Right, the AcQMap next-generation mapping catheter integrates high-resolution ultrasound-based imaging and non-contact mapping catheter with improved torque response, handling and maneuverability.

Left, the AcQCross Transseptal Crossing Device offers versatility to be utilized with top sheaths currently used in left atrium EP and structural heart procedures. Right, the AcQMap next-generation mapping catheter integrates high-resolution ultrasound-based imaging and non-contact mapping catheter with improved torque response, handling and maneuverability.

News | EP Lab | May 25, 2021
May 25, 2021 — Acutus Medical Inc.
Etripamil nasal spray was shown in a post-hoc analysis to resolve paroxysmal supraventricular tachycardia faster and more completely than placebo in most patients and reduced the number of emergency room visits for additional interventions. 

Etripamil nasal spray was shown in a post-hoc analysis to resolve paroxysmal supraventricular tachycardia faster and more completely than placebo in most patients and reduced the number of emergency room visits for additional interventions. 

Feature | EP Lab | May 16, 2021 | By Dave Fornell, Editor
May 16, 2020 — New data from in the ...
A device programmer showing the suspension of ICD therapies (orange bar, red arrow) with iPhone 12 laying over patient’s chest (green arrow) and fluoroscopy of iPhone 12 showing the circular magnet array (yellow arrow). Image from a small study at Henry Ford Hospital. Read the full study

A device programmer showing the suspension of ICD therapies (orange bar, red arrow) with iPhone 12 laying over patient’s chest (green arrow) and fluoroscopy of iPhone 12 showing the circular magnet array (yellow arrow). Image from a small study at Henry Ford Hospital. Read the full study

News | EP Lab | May 14, 2021
May 14, 2021 — The U.S.
Abbott Recalls Assurity and Endurity Pacemakers 
News | EP Lab | May 14, 2021
May 14, 2021 — Abbott is recalling a subset of Assurity and Endurity...
EP lab at the University of Colorado
News | EP Lab | May 12, 2021
May 12, 2021 — Galaxy Medical and Japan Lifeline announced an exclusive distribution agreement for the Alpha1 ablatio
The Bluegrass Vascular Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. 

The Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. 

News | EP Lab | May 06, 2021
May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility
Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for anxiety and depression, according to research presented at European Heart Rhythm Association (EHRA) 2021 conference. ICD depression
News | EP Lab | April 26, 2021
April 26, 2021 — Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for
Former Vice President Mike Pence. Photo by Airman 1st Class Aubree Owens, 30th Space Wing Public Affairs

Photo by Airman 1st Class Aubree Owens, 30th Space Wing Public Affairs

News | EP Lab | April 19, 2021
April 19, 2021 — Former Vice President Mike Pence is recovering after having a...